Sephoris Pharmaceuticals LLC
Israel
- Country
- Israel
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn
Phase 2
Terminated
- Conditions
- Sunburn
- Interventions
- Drug: 2 capsules Ibuprofen and 1 placebo
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- Sephoris Pharmaceuticals LLC
- Target Recruit Count
- 80
- Registration Number
- NCT03332524
- Locations
- 🇲🇺
CIDP, Phoenix, Mauritius
© Copyright 2025. All Rights Reserved by MedPath